Connect your AI

Organon OGN Total Liabilities & Equity

Total Liabilities & Equity at other companies

PfizerPFE

$207.62B-0.2%

AmgenAMGN

$92.5B+3.5%

The Cooper Companies, Inc.COO

$12.48B+0.6%

BiogenBIIB

$29.48B+5.2%

AbbVieABBV

$136.46B+0.2%

Amneal Pharmaceuticals, Inc.AMRX

$3.54B+5.2%

Other financials

Income statement

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

Market cap$3.53B-59.4%

Profitability

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Organon's total liabilities & equity?: Organon (OGN) reported total liabilities & equity of $13B in Q1 2026.
How has Organon's total liabilities & equity changed year-over-year?: Organon's total liabilities & equity decreased by 1.2% year-over-year, from $13.16B to $13B.
What is the long-term trend for Organon's total liabilities & equity?: Over 5 years (2020 to 2025), Organon's total liabilities & equity has grown at a 4.9% compound annual growth rate (CAGR), from $10.11B to $12.87B.
What does total liabilities & equity mean?: Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.